Abstract
Summary
Our study indicates that hip fracture is independently associated with increased risk of developing stroke. In addition, the risk of stroke following the incidence of hip fracture is more prominent in younger patients, men, those with cardiovascular comorbidities, and in patients using specific medication, such as diuretics and ABRs.
Introduction
Hip fractures are associated with increased risk of major morbidity. However, few data are available on the risk of stroke after hip fracture. Therefore, we investigated whether hip fracture increases the risk of stroke in a large nationwide cohort study.
Methods
Using universal insurance claims data, we identified a study cohort comprising of 6013 newly diagnosed with hip fracture patients from 2000 to 2010 and a non-hip fracture cohort of 23,802 participants. Incidence and risk of stroke were estimated for both cohorts until the end of 2011.
Results
Stroke incidence was 1.69-fold (95 % confidence interval [CI] = 1.56–1.83) higher in the hip fracture cohort than in the comparison cohort with an adjusted hazard ratio (HR) of 1.54 (95 % CI = 1.42–1.67) for the hip fracture cohort. The hip fracture patients were at higher risk of developing ischemic stroke (HR = 1.55, 95 % CI = 1.42–1.69) and hemorrhagic stroke (HR = 1.55, 95 % CI = 1.16–1.89), respectively. At an incidence of 64.6 per 1000 person-years, the adjusted HR of stroke increases to 3.10 (95 % CI = 2.47–3.90) for patients with coexisting diabetes, hypertension, and heart failure compared with those without these three conditions. At an incidence of 60.4 per 1000 person-years, the adjusted HR of stroke increases to 2.92 (95 % CI = 2.43–3.51) for hip fracture patients prescribed with diuretics and angiotensin II receptor blockers (ARBs) compared with those without hip fracture or prescriptions for diuretics or ARBs.
Conclusions
Hip fracture is independently associated with a subsequent risk of stroke.
Similar content being viewed by others
References
Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359:1761–1767
Fisher AA, Davis MW, Rubenach SE, Sivakumaran S, Smith PN, Budge MM (2006) Outcomes for older patients with hip fractures: the impact of orthopedic and geriatric medicine co care. J Orthop Trauma 20:172–178, discussion 179–180
Bentler SE, Liu L, Obrizan M, Cook EA, Wright KB, Geweke JF, Chrischilles EA, Pavlik CE, Wallace RB, Ohsfeldt RL, Jones MP, Rosenthal GE, Wolinsky FD (2009) The aftermath of hip fracture: Discharge placement, functional status change, and mortality. Am J Epidemiol 170:1290–1299
Kannus P, Parkkari J, Sievanen H, Heinonen A, Vuori I, Jarvinen M (1996) Epidemiology of hip fractures. Bone 18:57S–63S
Melton LJ (2000) Who has osteoporosis? A conflict between clinical and public health perspectives. J Bone Miner Res 15:2309–2314
Sennerby U, Melhus H, Gedeborg R, Byberg L, Garmo H, Ahlbom A, Pedersen NL, Michaelsson K (2009) Cardiovascular diseases and risk of hip fracture. JAMA 302:1666–1673
Batsis JA, Huddleston JM, Melton LJ, Huddleston PM, Lopez-Jimenez F, Larson DR, Gullerud RE, McMahon MM (2009) Body mass index and risk of adverse cardiac events in elderly patients with hip fracture: a population-based study. J Am Geriatr Soc 57:419–426
McFarlane SI (2006) Bone metabolism and the cardiometabolic syndrome: Pathophysiologic insights. J Cardiometab Syndr 1:53–57
McFarlane SI, Muniyappa R, Shin JJ, Bahtiyar G, Sowers JR (2004) Osteoporosis and cardiovascular disease: Brittle bones and boned arteries, is there a link? Endocrine 23:1–10
Chiang CH, Liu CJ, Chen PJ, Huang CC, Hsu CY, Chen ZY, Chan WL, Huang PH, Chen TJ, Chung CM, Lin SJ, Chen JW, Leu HB (2013) Hip fracture and risk of acute myocardial infarction: a nationwide study. J Bone Miner Res 28:404–411
Cheng CL, Kao YH, Lin SJ, Lee CH, Lai ML (2011) Validation of the national health insurance research database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf 20:236–242
Chung WS, Lin CL, Peng CL, Chen YF, Lu CC, Sung FC, Kao CH (2013) Rheumatoid arthritis and risk of acute myocardial infarction—a nationwide retrospective cohort study. Int J Cardiol 168:4750–4754
Kang JH, Chung SD, Xirasagar S, Jaw FS, Lin HC (2011) Increased risk of stroke in the year after a hip fracture: a population-based follow-up study. Stroke; J Cerebral Circ 42:336–341
Popa AS, Rabinstein AA, Huddleston PM, Larson DR, Gullerud RE, Huddleston JM (2009) Predictors of ischemic stroke after hip operation: a population-based study. J Hosp Med 4:298–303
Wong LS, de Boer RA, Samani NJ, van Veldhuisen DJ, van der Harst P (2008) Telomere biology in heart failure. Eur J Heart Fail 10:1049–1056
Valdes AM, Richards JB, Gardner JP, Swaminathan R, Kimura M, Xiaobin L, Aviv A, Spector TD (2007) Telomere length in leukocytes correlates with bone mineral density and is shorter in women with osteoporosis. Osteoporos Int 18:1203–1210
Baldini V, Mastropasqua M, Francucci CM, D’Erasmo E (2005) Cardiovascular disease and osteoporosis. J Endocrinol Invest 28:69–72
Hofbauer LC, Brueck CC, Shanahan CM, Schoppet M, Dobnig H (2007) Vascular calcification and osteoporosis—from clinical observation towards molecular understanding. Osteoporos Int 18:251–259
Theill LE, Boyle WJ, Penninger JM (2002) Rank-l and rank: T cells, bone loss, and mammalian evolution. Annu Rev Immunol 20:795–823
Dharmarajan TS, Banik P (2006) Hip fracture. Risk factors, preoperative assessment, and postoperative management. Postgrad Med 119:31–38
Tateishi Y, Iguchi Y, Kimura K, Kobayashi K, Shibazaki K, Eguchi K (2009) Right-to-left shunts may be not uncommon cause of tia in japan. J Neurol Sci 277:13–16
Bannan A, Shen R, Silvestry FE, Herrmann HC (2009) Characteristics of adult patients with atrial septal defects presenting with paradoxical embolism. Catheter Cardiovasc Interv 74:1066–1069
Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Au R, Kannel WB, Wolf PA (2006) The lifetime risk of stroke: Estimates from the framingham study. Stroke; J Cerebral Circ 37:345–350
Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, Haase N, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O’Donnell CJ, Roger V, Rumsfeld J, Sorlie P, Steinberger J, Thom T, Wasserthiel-Smoller S, Hong Y (2007) Heart disease and stroke statistics–2007 update: a report from the American heart association statistics committee and stroke statistics subcommittee. Circulation 115:e69–171
Tinetti ME, Han L, Lee DS, McAvay GJ, Peduzzi P, Gross CP, Zhou B, Lin H (2014) Antihypertensive medications and serious fall injuries in a nationally representative sample of older adults. JAMA Intern Med 174:588–595
Wilson D, Cooke EA, McNally MA, Wilson HK, Yeates A, Mollan RA (2002) Altered venous function and deep venous thrombosis following proximal femoral fracture. Injury 33:33–39
Ylinenvaara SI, Elisson O, Berg K, Zdolsek JH, Krook H, Hahn RG (2014) Preoperative urine-specific gravity and the incidence of complications after hip fracture surgery: a prospective, observational study. Eur J Anaesthesiol 31:85–90
Rosencher N, Vielpeau C, Emmerich J, Fagnani F, Samama CM (2005) Venous thromboembolism and mortality after hip fracture surgery: the escorte study. J Thrombosis Haemostasis: JTH 3:2006–2014
Camm JA (2010) Review of the cardiovascular safety of zoledronic acid and other bisphosphonates for the treatment of osteoporosis. Clin Ther 32:426–436
Black DM, Reid IR, Boonen S, Bucci-Rechtweg C, Cauley JA, Cosman F, Cummings SR, Hue TF, Lippuner K, Lakatos P, Leung PC, Man Z, Martinez RL, Tan M, Ruzycky ME, Su G, Eastell R (2012) The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the horizon-pivotal fracture trial (pft). J Bone Miner Res 27:243–254
Sharma A, Chatterjee S, Arbab-Zadeh A, Goyal S, Lichstein E, Ghosh J, Aikat S (2013) Risk of serious atrial fibrillation and stroke with use of bisphosphonates: Evidence from a meta-analysis. Chest 144:1311–1322
Huang WF, Tsai YW, Wen YW, Hsiao FY, Kuo KN, Tsai CR (2010) Osteoporosis treatment and atrial fibrillation: Alendronate versus raloxifene. Menopause 17:57–63
Acknowledgments
This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW103-TDU-B-212-113002), China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project (BM103010096), NRPB Stroke Clinical Trial Consortium (MOST 103-2325-B-039-006-), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan.
Conflicts of interest
None
Author information
Authors and Affiliations
Corresponding author
Additional information
All authors have contributed significantly, and that all authors are in agreement with the content of the manuscript: Conception/Design: Wei-Sheng Chung, Chun-Hao Tsai; Collection and/or assembly of data: All authors; Data analysis and interpretation: Wei-Sheng Chung, Chun-Hao Tsai, Cheng-Li Lin; Manuscript writing: All authors; Final approval of manuscript: All authors
Rights and permissions
About this article
Cite this article
Tsai, CH., Lin, CL., Hsu, HC. et al. Increased risk of stroke among hip fracture patients: a nationwide cohort study. Osteoporos Int 26, 645–652 (2015). https://doi.org/10.1007/s00198-014-2919-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-014-2919-7